comparemela.com

Latest Breaking News On - Semmes distinguished university - Page 1 : comparemela.com

Case study: Experimental lecanemab treatment causes adverse outcomes in 65-year-old woman with Alzheimer s disease

In a noteworthy case study published in the Journal of Alzheimer's Disease investigators report autopsy findings in a 65-year-old woman with Alzheimer's disease (AD) who received three open label infusions of the experimental anti-amyloid beta (Aβ) antibody drug lecanemab.

COVID-19 Strikes Again: Accelerating Dementia in the Most Vulnerable

All subtypes of dementia, irrespective of patients’ previous dementia types, behaved like rapidly progressive dementia following COVID-19, according to the Journal of Alzheimer’s Disease Reports Infection with SARS-CoV-2 has a significant impact on cognitive function in patients with preexisting

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.